Lantern Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $17,877,570.
Profit Margin
| 2018 | 0 | -1.72M | |
|---|---|---|---|
| 2019 | 0 | -2.42M | |
| 2020 | 0 | -5.90M | |
| 2021 | 0 | -12.29M | |
| 2022 | 0 | -14.08M | |
| 2023 | 0 | -15.96M |
LTRN Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 174.84K | 154.68K | 97.42K | 3.38K | 1.62K | 0 |
Gross profit | -174.84K | -154.68K | -97.42K | -3.38K | -1.62K | 0 |
Operating exp. | ||||||
Research and development | 11.89M | 8.60M | 7.57M | 2.24M | 953.18K | 572.09K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 17.87M | 14.43M | 12.59M | 5.90M | 2.42M | 1.72M |
Operating income | -17.87M | -14.43M | -12.59M | -5.90M | -2.42M | -1.72M |
Other income (expenses), net | 1.91M | 172.80K | 228.47K | 0 | -5 | 0 |
Income before tax | -15.96M | -14.25M | -12.36M | -5.90M | -2.42M | -1.72M |
Income tax expense | 0 | -172.80K | -67.92K | -202.90K | -5 | 2.54K |
Net income | -15.96M | -14.08M | -12.29M | -5.90M | -2.42M | -1.72M |
Earnings per share | ||||||
Basic EPS | -1.47 | -1.3 | -1.13 | -0.95 | -0.39 | -0.28 |
Diluted EPS | -1.47 | -1.3 | -1.13 | -0.95 | -0.39 | -0.28 |
| Data source | Data source | Data source | Data source |